151 related articles for article (PubMed ID: 23728171)
21. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
[TBL] [Abstract][Full Text] [Related]
22. Factor H-related proteins determine complement-activating surfaces.
Józsi M; Tortajada A; Uzonyi B; Goicoechea de Jorge E; Rodríguez de Córdoba S
Trends Immunol; 2015 Jun; 36(6):374-84. PubMed ID: 25979655
[TBL] [Abstract][Full Text] [Related]
23. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
Reuter M; Caswell CC; Lukomski S; Zipfel PF
J Biol Chem; 2010 Dec; 285(49):38473-85. PubMed ID: 20855886
[TBL] [Abstract][Full Text] [Related]
24. Complement and kidney disease, new insights.
Medjeral-Thomas NR; Pickering MC; Cook HT
Curr Opin Nephrol Hypertens; 2021 May; 30(3):310-316. PubMed ID: 33767058
[TBL] [Abstract][Full Text] [Related]
25. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
26. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
27. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
[TBL] [Abstract][Full Text] [Related]
28. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
Ruseva MM; Peng T; Lasaro MA; Bouchard K; Liu-Chen S; Sun F; Yu ZX; Marozsan A; Wang Y; Pickering MC
J Am Soc Nephrol; 2016 Feb; 27(2):405-16. PubMed ID: 26047789
[TBL] [Abstract][Full Text] [Related]
30. Factor H Autoantibodies and Complement-Mediated Diseases.
Zhang Y; Ghiringhelli Borsa N; Shao D; Dopler A; Jones MB; Meyer NC; Pitcher GR; Taylor AO; Nester CM; Schmidt CQ; Smith RJH
Front Immunol; 2020; 11():607211. PubMed ID: 33384694
[TBL] [Abstract][Full Text] [Related]
31. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
[TBL] [Abstract][Full Text] [Related]
32. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
Lesher AM; Zhou L; Kimura Y; Sato S; Gullipalli D; Herbert AP; Barlow PN; Eberhardt HU; Skerka C; Zipfel PF; Hamano T; Miwa T; Tung KS; Song WC
J Am Soc Nephrol; 2013 Jan; 24(1):53-65. PubMed ID: 23204401
[TBL] [Abstract][Full Text] [Related]
33. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
Chen YY; Han SS; Cao Y; Yu XJ; Zhu L; Luo JC; Song WC; Yu F; Mao YH; Zhao MH
Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915
[TBL] [Abstract][Full Text] [Related]
34. Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
Chen Q; Wiesener M; Eberhardt HU; Hartmann A; Uzonyi B; Kirschfink M; Amann K; Buettner M; Goodship T; Hugo C; Skerka C; Zipfel PF
J Clin Invest; 2014 Jan; 124(1):145-55. PubMed ID: 24334459
[TBL] [Abstract][Full Text] [Related]
35. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
36. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
37. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
38. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
Whaley K; Thompson RA
Immunology; 1978 Dec; 35(6):1045-9. PubMed ID: 83964
[TBL] [Abstract][Full Text] [Related]
39. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
Pandiripally V; Gregory E; Cue D
Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
[TBL] [Abstract][Full Text] [Related]
40. The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy.
Kadkhodayi-Kholghi N; Bhatt JS; Gor J; McDermott LC; Gale DP; Perkins SJ
J Biol Chem; 2020 Nov; 295(48):16342-16358. PubMed ID: 32928961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]